Skip to content
value.today

RefleXion Medical, Inc.

Formerly RefleXion, Inc.

Total raised
$413 M
6 rounds on record
Latest round
$107 M
Nov 2023
First round on record
Mar 2014
Today
Private
No later event on record

Funding rounds

6 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of RefleXion Medical, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Nov 2023$107 MNo. 6$50 to $250 million

RefleXion Medical, Inc.: Raise no. 6, Nov 2023

Investors in this round

43 investors had bought by the notice of Nov 22, 2023: 43 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$107 M of $201 M offered; $95 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • David T. Larkin · Executive Officer
  • Diana J. King · Executive Officer
  • Gopinath J. Kuduvalli · Executive Officer
  • Jeffrey T. Holifield · Executive Officer
  • Judy J. Bartlett-Roberto · Executive Officer
  • Kathy J. O'Shaughnessy · Executive Officer
  • Leena J. Kadakia · Executive Officer
  • Leonard J. Lyons · Executive Officer
  • Martyn T. Webster · Executive Officer
  • Philip J. Aulson II · Executive Officer
  • Samuel Mazin · Executive Officer, Director
  • Sean T. Shirvani · Executive Officer
  • Thorsten J. Melcher · Executive Officer
  • Todd Powell · Executive Officer, Director
  • Alice T. Schroeder · Director
  • Art T. Heidrich · Director
  • Cem T. Usakli · Director
  • Fred Moll · Director
  • Greg Garfield · Director
  • Jay Watkins · Director
  • Kevin T. Reilly · Director
  • Matthew T. Hobart · Director
  • Rana T. Al-Hallaq · Director
  • Renee T. Ryan · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Jeffrey Holifield, Vice President, Head of Legal. Source: SEC Form D, newest notice filed Nov 22, 2023. Read the notice at the SEC.

equity, optionsSEC
Mar 2022$81 MNo. 5$50 to $250 million

RefleXion Medical, Inc.: Raise no. 5, Mar 2022

Investors in this round

31 investors had bought by the notice of Mar 16, 2022: 31 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$81 M of $110 M offered; $29 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • David J. Leung · Executive Officer
  • David Larkin · Executive Officer
  • Gopinath Kuduvalli · Executive Officer
  • Jeff J. Holifield · Executive Officer
  • Judy J. Bartlett-Roberto · Executive Officer
  • Kathy J. O'Shaughnessy · Executive Officer
  • Leonard J. Lyons · Executive Officer
  • Martyn Webster · Executive Officer
  • Philip J. Aulson II · Executive Officer
  • Samuel Mazin · Executive Officer, Director
  • Sean Shirvani · Executive Officer
  • Thorsten Melcher · Executive Officer
  • Todd Powell · Executive Officer, Director
  • Alice Schroeder · Director
  • Antoine Papiernik · Director
  • Cem Usakli · Director
  • Fred Moll · Director
  • Greg Garfield · Director
  • Jay Watkins · Director
  • Matthew Hobart · Director
  • Rana Al-Hallaq · Director
  • Renee Ryan · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Jeff Holifield, Vice President and Head of Legal. Source: SEC Form D, newest notice filed Mar 16, 2022. Read the notice at the SEC.

equitySEC
Apr 2020$100 MNo. 4$50 to $250 million

RefleXion Medical, Inc.: Raise no. 4, Apr 2020

Investors in this round

17 investors had bought by the notice of Apr 17, 2020: 17 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$100 M of $125 M offered; $25 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$2,000,000
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks sales commissions as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Martyn Webster · Executive Officer
  • Samuel Mazin · Executive Officer, Director
  • Todd Powell · Executive Officer, Director
  • Antoine Papiernik · Director
  • Bill Burkoth · Director
  • Fred Moll · Director
  • Greg Garfield · Director
  • Jay Watkins · Director
  • Loic Jule · Director
  • Matthew Hobart · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Morgan Stanley & Co. LLC (CRD 8209) · New York, New YorkSold in all US states
  • BofA Securities, Inc. (CRD 283942) · New York, New YorkSold in all US states

Remarks in the notice

  • On fees: “Sales commissions estimates are for the total amount sold as recorded in item 13 and evenly divided between the two recipients recorded in item 12.”

Signed by Martyn Webster, Secretary and CFO. Source: SEC Form D, newest notice filed Apr 17, 2020. Read the notice at the SEC.

equitySEC
Mar 2018$97 MNo. 3$50 to $250 million

RefleXion Medical, Inc.: Raise no. 3, Mar 2018

Investors in this round

18 investors had bought by the notice of Apr 2, 2018: 18 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$97 M of $103 M offered; $6 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Samuel Mazin · Executive Officer, Director
  • Todd Powell · Executive Officer, Director
  • Antoine Papiernik · Director
  • Bill Burkoth · Director
  • Fred Moll · Director
  • Greg Garfield · Director
  • Jay Watkins · Director
  • Matthew Hobart · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Todd M. Powell, President and ceo. Source: SEC Form D, newest notice filed Apr 2, 2018. Read the notice at the SEC.

equitySEC
Apr 2016$23 MNo. 2$10 to $50 million

RefleXion Medical, Inc.: Raise no. 2, Apr 2016

Investors in this round

5 investors had bought by the notice of Apr 19, 2016: 5 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$23 M of $52 M offered; $29 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
more than a year
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Akshay Nanduri · Executive Officer, Director
  • Samuel Mazin · Executive Officer, Director
  • Antoine Papiernik · Director
  • Colin Cahill · Director
  • Fred Moll · Director
  • Greg Garfield · Director
  • Jay Watkins · Director
  • Nael Kassar · Director
  • William Burkoth · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Samuel Mazin, President. Source: SEC Form D, newest notice filed Apr 19, 2016. Read the notice at the SEC.

equitySEC
Mar 2014$6 MNo. 1$2 to $10 million

RefleXion Medical, Inc.: Raise no. 1, Mar 2014

Investors in this round

19 investors had bought by the notice of Apr 4, 2014: 19 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$6 M of $12 M offered; $6 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
$80,000 (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Akshay Nanduri · Executive Officer, Director
  • Samuel Mazin · Executive Officer, Director
  • Jay Watkins · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Samuel Mazin, President. Source: SEC Form D, newest notice filed Apr 4, 2014. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • RefleXion Medical, Inc. chose not to state its revenue in its newest notice of a funding round (Nov 2023).

    SEC Form D · Nov 2023

  • The industry group it chose in its notices: Other Health Care.

    SEC Form D · Nov 2023

That is all the official record says: RefleXion Medical, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of RefleXion Medical, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 6 rounds above had up to 43 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by RefleXion Medical, Inc.
NameRoleNamed in
David T. LarkinExecutive officerNov 2023
Diana J. KingExecutive officerNov 2023
Gopinath J. KuduvalliExecutive officerNov 2023
Jeffrey T. HolifieldExecutive officerNov 2023
Judy J. Bartlett-RobertoExecutive officerNov 2023
Kathy J. O'ShaughnessyExecutive officerNov 2023
Leena J. KadakiaExecutive officerNov 2023
Leonard J. LyonsExecutive officerNov 2023
Martyn T. WebsterExecutive officerNov 2023
Philip J. Aulson IIExecutive officerNov 2023
Samuel MazinExecutive officerNov 2023
Sean T. ShirvaniExecutive officerNov 2023
Thorsten J. MelcherExecutive officerNov 2023
Todd PowellExecutive officerNov 2023
David J. LeungExecutive officerMar 2022
David LarkinExecutive officerMar 2022
Gopinath KuduvalliExecutive officerMar 2022
Jeff J. HolifieldExecutive officerMar 2022
Martyn WebsterExecutive officerMar 2022
Sean ShirvaniExecutive officerMar 2022
Thorsten MelcherExecutive officerMar 2022
Akshay NanduriExecutive officerApr 2016
Alice T. SchroederDirectorNov 2023
Art T. HeidrichDirectorNov 2023
Cem T. UsakliDirectorNov 2023
Fred MollDirectorNov 2023
Greg GarfieldDirectorNov 2023
Jay WatkinsDirectorNov 2023
Kevin T. ReillyDirectorNov 2023
Matthew T. HobartDirectorNov 2023
Rana T. Al-HallaqDirectorNov 2023
Renee T. RyanDirectorNov 2023
Samuel MazinDirectorNov 2023
Todd PowellDirectorNov 2023
Alice SchroederDirectorMar 2022
Antoine PapiernikDirectorMar 2022
Cem UsakliDirectorMar 2022
Matthew HobartDirectorMar 2022
Rana Al-HallaqDirectorMar 2022
Renee RyanDirectorMar 2022